2009
DOI: 10.1016/s1569-9056(09)60481-4
|View full text |Cite
|
Sign up to set email alerts
|

483 Treatment of Voiding Dysfunction by Neuromodulation in a Selected MS Patient Population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2010
2010
2010
2010

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
0
0
Order By: Relevance
“…Recently, Van Rey has reported in a selected MS patient population that despite a 61% positive response rate to the first stage, at two years of follow-up neuromodulation remained efficient in only 18% of the implanted patients, the efficacy being lost with progression of the neurological disease in all cases [22]. The conclusion from this study therefore is that this costly intervention should probably not be undertaken in patients with MS.…”
Section: Resultsmentioning
confidence: 63%
“…Recently, Van Rey has reported in a selected MS patient population that despite a 61% positive response rate to the first stage, at two years of follow-up neuromodulation remained efficient in only 18% of the implanted patients, the efficacy being lost with progression of the neurological disease in all cases [22]. The conclusion from this study therefore is that this costly intervention should probably not be undertaken in patients with MS.…”
Section: Resultsmentioning
confidence: 63%